At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 161 enrolled
Drug / intervention
0.3% Saline in 3.3% dextrose +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Use of Isotonic Solutions Versus Hypotonic Solutions for Preventing Hospital Acquired Hyponatremia.
Instituto Tecnologico y de Estudios Superiores de Monterey·interventional·Posted Jul 26, 2013·Updated Dec 16, 2016
In Brief
A Phase 3 clinical trial evaluating 0.3% Saline in 3.3% dextrose, 0.45% Saline in 5% dextrose, and 1 other intervention for Hyponatremia. Completed, enrolled 161 participants.
Detailed Summary
The purpose of this study is to determine if isotonic solutions reduce the risk of hospital acquired hyponatremia compared with hypotonic solutions.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHyponatremia
Countries--
CollaboratorsTecnologico de Monterrey
Timeline
Phase 3CompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartJul 2013
First PostedJul 2013
Primary CompletionFeb 2014
Study CompletionApr 2014
TodayJul 2026
First PostedJul 26, 2013
Enrollment StartJul 1, 2013
Primary CompletionFeb 1, 2014
Study CompletionApr 1, 2014
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 12.9 years ago
Interventions
0.3% Saline in 3.3% dextrosedrug
Hypotonic Solutions: 0.3% Saline in 3.3% dextrose
0.45% Saline in 5% dextrosedrug
Hypotonic Solutions: 0.45% Saline in 5% dextrose
0.9% Saline in 5% dextrosedrug
Isotonic Solutions 0.9% Saline in 5% dextrose